Daily Health Headlines

Almost 13 Million More Americans Could Take Statins Under New Guidelines

👤by Robert Preidt 0 comments 🕔Thursday, March 20th, 2014

WEDNESDAY, March 19, 2014 (HealthDay News) -- Nearly 13 million more Americans will be eligible to take cholesterol-lowering statin drugs under new guidelines, and most of those additional users will be older than 60, researchers say.

The American Heart Association guidelines were released last November and expanded the criteria for statin use to include people with an increased risk of developing heart disease over a 10-year period.

Statin drugs include atorvastatin (sold under the brand name Lipitor), simvastatin (Zocor), lovastatin (Mevacor), pravastatin (Pravachol) and rosuvastatin (Crestor).

In this study, researchers used data from more than 3,700 Americans, aged 40 to 75, to determine how the new guidelines would affect the number of people who use statins.

"By our estimate, there might be an uptick in usage as a result of the guidelines, from 43.2 million people to 56 million, which is nearly half of the U.S. population between the ages of 40 and 75," lead author Michael Pencina, a professor of biostatistics at Duke University's Clinical Research Institute, said in a university news release.

A large increase in usage would occur among people older than 60, with 77 percent eligible for statins under the new guidelines compared to 48 percent under the previous standards.

The use of statins among people aged 40 to 60 would increase only from 27 percent to 30 percent, the researchers said.

Men aged 60 to 75 who are not taking statins and do not have heart disease would be most affected by the new recommendations, with the number who are eligible increasing from about 30 percent to 87 percent, according to the study, which was published online March 19 in the New England Journal of Medicine.

The use of statins among healthy women in this age group would rise from 21 percent to 53 percent.

On the other hand, the researchers also found that about 1.6 million adults who were previously eligible for statins would no longer be candidates for the drugs. Most of these people are young adults who have elevated cholesterol but a low 10-year risk of heart disease.

"Recommendations are just that -- recommendations," Pencina said. "These guidelines correctly call for a thorough discussion between the doctor and patient about the risks and benefits of statins. It's not like everybody who meets the guidelines should all of a sudden go on statins."

-- Robert Preidt

Article Credits / Source

Robert Preidt / HealthDay

Robert Preidt wrote this story for HealthDay. HealthDay provides up to the minute breaking health news. Click here to view this full article from HealthDay.

SOURCE: Duke Medicine, news release, March 19, 2014

View More Articles From Robert Preidt 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Cholesterol Articles

Lipitor (atorvastatin)

Lipitor (atorvastatin)0

home / cholesterol center / cholesterol a-z list / atorvastatin index / lipitor (atorvastatin) drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...

gemfibrozil, Lopid

gemfibrozil, Lopid0

home / cholesterol center / cholesterol a-z list / gemfibrozil index / gemfibrozil, lopid drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his Doctorate ...

fenofibrate (Antara, Fenoglide, Fibricor, Lipofen, Lofibra, Tricor, Triglide,  Trilipix)

fenofibrate (Antara, Fenoglide, Fibricor, Lipofen, Lofibra, Tricor, Triglide, Trilipix)0

home / cholesterol center / cholesterol a-z list / fenofibrate-oral index / fenofibrate (antara, fenoglide, fibricor, lipofen, lofibra, tricor, triglide, trilipix) drug monograph Pharmacy Author: ...

Are There Alternatives to Statins?

Are There Alternatives to Statins?0

TUESDAY, Sept. 27, 2016 (HealthDay News) -- Statins are the go-to therapy for lowering "bad" LDL cholesterol, but other treatments also can effectively reduce risk of future heart problems, a new evidence review reports. These alternative ...

Repatha (evolocumab)

Repatha (evolocumab)0

home / cholesterol center / cholesterol a-z list / evolocumab index / repatha (evolocumab) drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his Doctorate ...

View More Cholesterol Articles


Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!